Pharmaceutical Antitrust Case in the News

Generic Line reports that Organon and its parent company, Akzo Nobel, entered into $ 36 million settlement with the AG's of all 50 states to resolve state antitrust claims stemming from anticompetitive acts related to its anti-depression drug Remeron.  The claims alleged that the two companies took steps to block the entry of generic competition, including fraudulent claims about its patents made to the FDA.